We give no better than 50% odds to CMS forestalling an implied facility cut of 25%+ for Shockwave’s (SWAV) C2 coronary intravascular lithotripsy (IVL) procedures, once its Transitional Pass-Through (TPT) payment ends next year as part of the agency’s CY24 hospital outpatient/ASC proposed rule due out in early July.
Policy & Legal, Research
Shockwave (SWAV): Volatility Ahead?
09 February 2023
Summary
Want to learn more? Download the Report.
Solutions
Public Policy & Legal Research
Identify opportunity and risk driven by public policy and the courts.
Fundamental Equity Research
Gain a comprehensive view of global themes, industries, and companies.